Acquired marked hypertriglyceridemia with anti-GPIHBP1 antibodies

Pediatr Int. 2020 May;62(5):651-653. doi: 10.1111/ped.14154.
No abstract available

Keywords: GPIHBP1; SLE; autoimmune dyslipidemia; hypertriglyceridemia.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use
  • Autoantibodies / immunology*
  • Diet, Fat-Restricted / methods
  • Female
  • Fenofibrate / therapeutic use
  • Humans
  • Hypertriglyceridemia / complications*
  • Hypertriglyceridemia / diagnosis
  • Hypertriglyceridemia / therapy
  • Hypolipidemic Agents / therapeutic use
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy
  • Pancreatitis / complications
  • Pancreatitis / diagnosis
  • Prednisolone / therapeutic use
  • Receptors, Lipoprotein / immunology*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • GPIHBP1 protein, human
  • Hypolipidemic Agents
  • Receptors, Lipoprotein
  • Prednisolone
  • Fenofibrate